Chester A, Scott J, Anant S, Navaratnam N
MRC Molecular Medicine, Clinical Science Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Biochim Biophys Acta. 2000 Nov 15;1494(1-2):1-13. doi: 10.1016/s0167-4781(00)00219-0.
RNA editing is a post-transcriptional process that changes the informational capacity within the RNA. These processes include alterations made by nucleotide deletion, insertion and base conversion. A to I and C to U conversion occurs in mammals and these editing events are catalysed by RNA binding deaminases. C to U editing of apoB mRNA was the first mammalian editing event to be identified. The minimal protein complex necessary for apoB mRNA editing has been determined and consists of APOBEC-1 and ACF. Overexpression of APOBEC-1 in transgenic animals caused liver dysplasia and APOBEC-1 has been identified in neurofibromatosis type 1 tumours, suggesting that RNA editing may be another mechanism for tumourigenesis. Several APOBEC-1-like proteins have been identified, including a family of APOBEC-1-related proteins with unknown function on chromosome 22. This review summarises the different types of RNA editing and discusses the current status of C to U apoB mRNA editing. This knowledge is very important in understanding the structure and function of these related proteins and their role in biology.
RNA编辑是一种改变RNA信息容量的转录后过程。这些过程包括核苷酸缺失、插入和碱基转换所导致的改变。在哺乳动物中会发生A到I以及C到U的转换,这些编辑事件由RNA结合脱氨酶催化。载脂蛋白B(apoB)mRNA的C到U编辑是首个被鉴定出的哺乳动物编辑事件。已经确定了apoB mRNA编辑所需的最小蛋白质复合物,它由载脂蛋白B mRNA编辑酶催化多肽1(APOBEC-1)和激活因子(ACF)组成。在转基因动物中过表达APOBEC-1会导致肝脏发育异常,并且在1型神经纤维瘤病肿瘤中也发现了APOBEC-1,这表明RNA编辑可能是肿瘤发生的另一种机制。已经鉴定出几种APOBEC-1样蛋白,包括22号染色体上一组功能未知的APOBEC-1相关蛋白。本综述总结了不同类型的RNA编辑,并讨论了apoB mRNA的C到U编辑的现状。这些知识对于理解这些相关蛋白的结构和功能及其在生物学中的作用非常重要。